InvestorsHub Logo
Followers 35
Posts 4279
Boards Moderated 0
Alias Born 12/12/2007

Re: None

Thursday, 07/09/2020 1:07:41 PM

Thursday, July 09, 2020 1:07:41 PM

Post# of 401686
Currently trading at a $66 million market valuation ELTP is an exciting story developing in small caps with a number of FDA approved drugs already on the market as well as many more in the pipeline in various stages with numerous partners reporting significant sales of $18 million for fiscal 2019 and already $7 million for Q1 2020. The fast rise in revenues on ELTP was largely attributed to revenues from products launched during the 2020 Fiscal Year, generic immediate release Adderall®, generic extended release Adderall®, and generic Dantrolene Capsules, as well as strong growth in revenues relating to the sales of Isradipine capsules. We will be updating on ELTP when more details emerge so make sure you are subscribed to Microcapdaily so you know what’s going on with ELTP.


https://microcapdaily.com/the-buzz-on-elite-pharmaceuticals-inc-otcbbeltp/126297/
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ELTP News